Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Yahr

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1995
In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolismT Brannan, A Prikhojan, J Martínez-Tica, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 11, 1998
Sertraline induced parkinsonism. A case report and an in-vivo study of the effect of sertraline on dopamine metabolismA Di Rocco, T Brannan, A Prikhojan, et al.
Journal of Neural Transmission|January 1, 1981
The development of the dog nigrostriatal system in organotypic cultureW O Whetsell, C Mytilineou, J Shen, et al.
Neurology|January 1, 1976
Trichinosis: severe myopathic involvement with recoveryM J Davis, M Cilo, A Plaitakis, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline)M D Yahr, M R Mendoza, D Moros, et al.
Journal of Neural Transmission. Supplementum|January 1, 1980
Spiroperidol binding in the human caudate nucleusM H Winkler, S Berl, W O Whetsell, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1995
The use of famotidine in the treatment of Parkinson's disease: a pilot studyS P Molinari, R Kaminski, A Di Rocco, et al.
Neurology|June 1, 1988
Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine)H Kaufmann, T Brannan, L Krakoff, et al.
Archives of Neurology|October 1, 1978
Protein-rich cytoplasmic bodies of substantia nigra and locus ceruleus. A comparative study in parkinsonian and normal brainM R Issidorides, C Mytilineou, W O Whetsell, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Low and high dose bromocriptine have different effects on striatal dopamine release: an in vivo studyT Brannan, J Martínez-Tica, A Di Rocco, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1995
In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolismT Brannan, A Prikhojan, J Martínez-Tica, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 11, 1998
Sertraline induced parkinsonism. A case report and an in-vivo study of the effect of sertraline on dopamine metabolismA Di Rocco, T Brannan, A Prikhojan, et al.
Journal of Neural Transmission|January 1, 1981
The development of the dog nigrostriatal system in organotypic cultureW O Whetsell, C Mytilineou, J Shen, et al.
Neurology|January 1, 1976
Trichinosis: severe myopathic involvement with recoveryM J Davis, M Cilo, A Plaitakis, et al.
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Treatment of Parkinson's disease in early and late phases. Use of pharmacological agents with special reference to deprenyl (selegiline)M D Yahr, M R Mendoza, D Moros, et al.
Journal of Neural Transmission. Supplementum|January 1, 1980
Spiroperidol binding in the human caudate nucleusM H Winkler, S Berl, W O Whetsell, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1995
The use of famotidine in the treatment of Parkinson's disease: a pilot studyS P Molinari, R Kaminski, A Di Rocco, et al.
Neurology|June 1, 1988
Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine)H Kaufmann, T Brannan, L Krakoff, et al.
Archives of Neurology|October 1, 1978
Protein-rich cytoplasmic bodies of substantia nigra and locus ceruleus. A comparative study in parkinsonian and normal brainM R Issidorides, C Mytilineou, W O Whetsell, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Low and high dose bromocriptine have different effects on striatal dopamine release: an in vivo studyT Brannan, J Martínez-Tica, A Di Rocco, et al.
Pageof 10